Prevalence and associated factors of metabolic syndrome among Omani adults with mental illnesses: a cross-sectional study
Faisal Al Rashdi, Omar Al Omari, Blessy Prabha Valsaraj, Nasser Al-Sibani, Aziza Al Sawafi, Iman Al Hashmi, Maen Aljezawi, Mohammad Al Qadire, Mohammed ALBashtawy, Fadwa Alhalaiqa, Nasser AL Salmi

TL;DR
This study finds that nearly a third of Omani adults with mental illnesses have metabolic syndrome, highlighting the need for better metabolic screening and lifestyle support in psychiatric care.
Contribution
The first study in Oman to assess metabolic syndrome prevalence and risk factors among adults with mental illnesses.
Findings
Metabolic syndrome prevalence was 29.9% to 33.1% among Omani adults with mental illnesses.
Greater waist circumference and higher triglycerides increased odds of metabolic syndrome.
Higher physical activity and antidiabetic medication use were linked to lower odds of metabolic syndrome.
Abstract
Individuals with mental illnesses are at increased risk of developing metabolic syndrome (MetS), a cluster of cardiovascular and metabolic abnormalities. Despite growing evidence globally, there is a lack of research in the Gulf region, particularly in Oman. This study is the first to assess the prevalence and associated factors of MetS among Omani adults with mental illnesses. A descriptive cross-sectional design was employed. Three diagnostic criteria were used to assess MetS: the International Diabetes Federation (IDF) criteria, the modified Adult Treatment Panel III (ATP III), and the Joint Statement of the IDF Task Force with other organizations, aiming to enhance comparability and diagnostic consistency. A convenience sample of 251 Omani adults with mental illnesses was recruited from the outpatient departments of two tertiary hospitals in Muscat, Sultanate of Oman. Metabolic…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSchizophrenia research and treatment · Diabetes, Cardiovascular Risks, and Lipoproteins · HIV-related health complications and treatments
